Recent Finacing
Recent Raise
Amyl Therapeutics is a preclinical biotech developing ClariTY, a platform that conformationally binds amyloid folds across Aβ, Tau, α‑synuclein, AL and TTR to clear and block aggregate spread.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Amyl Therapeutics.
